Rocket Pharmaceuticals, Inc.

Senior Director, Analytical Development

Rocket Pharmaceuticals, Inc.$220K — $293K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD in biochemistry, analytical chemistry, or related discipline with 10 years experience, or MS with 12 years, or BS with 15 years in biotech/biopharma
  • Minimum 5 years of leadership experience
  • Proven experience in developing assays for cell and gene therapy in development and GMP environments
  • Direct experience with AAV or LV technologies and viral vector characterization preferred
  • Background in molecular (PCR), ELISA, HPLC/UPLC, and cell-based potency assays
  • Experience in method qualification, verification/validation, and method transfer to QC settings
  • Strong understanding of GMP and ICH guidelines

Responsibilities

  • Lead development and optimization of viral vector drug product release and characterization methods for GMP
  • Support drug substance and product development, including process characterization and quality attribute designations
  • Review and approve technical documents and method validation reports
  • Provide leadership and guidance to scientific staff
  • Develop, coach, and mentor a growing team of scientists

Benefits

  • Medical, dental, and vision insurance
  • Life insurance
  • 401(k) with company match and generous vesting
  • Paid vacation and holidays
  • Global shutdown days between Christmas and New Year’s
  • Wellness resources and employee support programs
  • Eligibility for bonuses and equity awards
Full Job Description
Overview

Position Summary

Rocket Pharma is seeking an experienced Senior Director, Analytical Development to join our Technical Development team. Reporting to the Vice President, Technical Development, the ideal candidate will have extensive experience and knowledge in assay development and a passion for tackling new challenges in a fast-paced, dynamic environment. This role will involve coordinating internal testing and development activities to support pipeline products, as well as providing leadership to a team of scientists.

 

We are looking for someone who is deeply curious about science and gene therapy and is motivated to translate innovative research into impactful therapies.

Responsibilities
  • Strategically lead and oversee the development and optimization of viral vector downstream and drug product release and characterization methods in preparation for transfer into a GMP environment
  • Analytically support drug substance process development and drug product development efforts, including characterization of processes and finished products, as well as establishing/refining Quality Attribute designations
  • Review and approve technical documents, standard operating procedures, method transfer/qualification/validation reports, specifications, and relevant study reports.
  • Provide hands-on leadership and guidance to scientific staff.
  • Foster the development, coaching, and mentoring of a growing team of scientists.
Qualifications
  • PhD in biochemistry, analytical chemistry, or a related biological science discipline, with 10 years99 experience in the biotechnology/biopharmaceutical industry in assay development or related fields in cell or gene therapy; M.S. with 12 years of relevant experience, or BS with 15 years of experience
  • Minimum 5 years leadership experience required
  • Proven experience developing assays to support cell and gene therapy programs in both development and GMP environments.
  • Candidates with direct experience in AAV or LV technologies, and/or expertise in viral vector biophysical characterization (e.g., particle distribution analysis, capsid characterization/modification, and viral genome sequencing), will be given strong consideration.
  • Extensive background in developing molecular (PCR), ELISA, HPLC/UPLC and cell-based potency assays
  • Significant experience qualifying, verifying/validating, and transferring analytical methods to a QC lab setting.
  • Strong understanding of GMP and ICH guidelines.
  • Proficient in Excel, JMP, and DNA analysis software.
  • Ability to thrive in a fast-paced environment, meet deadlines, and prioritize multiple projects.
  • Experience in leading teams and fostering the development of team members.
  • Excellent communication skills in technical writing and oral presentation.
  • A strong sense of responsibility, scientific rigor, accountability, and integrity.
  • Strong time management skills with the ability to prioritize tasks across multiple projects to meet deadlines.
Compensation

The expected salary range for this position is $220,000 to $293,000.

 

At Rocket, our compensation philosophy and ranges are built upon data and insights collected from validated world-class providers. We are committed to compensating employees equitably based on several factors, including responsibilities and level of the position, depth and types of the employee99s experience, location of the position and availability of similar talent in a competitive market.

 

For U.S.-based candidates, this is an at-will position, and Rocket reserves the right to adjust the range at hire or during the year due to market shifts.

 

In addition to base salary, Rocket offers a competitive total rewards package that may include bonuses (short-term incentives), medical, dental, and vision insurance, life insurance, 401(k) with company match and generous vesting, paid vacation and holidays, global shutdown days between Christmas and New Year99s, and a variety of wellness resources and employee support programs. Also, certain positions are eligible for added forms of compensation, such equity awards (long-term incentives).

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company that develops gene therapies for rare and devastating diseases. The company's pipeline includes gene therapies for Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Infantile Malignant Osteopetrosis. Rocket Pharmaceuticals' gene therapy platform is based on lentiviral vectors, which are designed to deliver genes to cells to correct genetic defects. The company was founded in 2015 and is headquartered in New York, New York.
Learn more about Rocket Pharmaceuticals, Inc.
Size
151 employees
Market Cap
$1.4 billion
Industry
Net Income
-$139.7 million
Founded
2015
NASDAQ

Similar Jobs

More Jobs at Rocket Pharmaceuticals, Inc.

More Pharmaceuticals & Biotech Jobs

Find similar Senior Director, Analytical Development jobs: